Subscribe Login
DE4CC0DE-5FC3-4494-BCBF-4D50B00366B5
A-Brands

GSK's Consumer Healthcare Business Posts Third-Quarter Growth

The consumer healthcare division of GlaxoSmithKline, which includes brands including Panadol and Aquafresh, has posted £2.5 billion (€2.9 billion) in sales in the third quarter of the group's financial year.

This is up 3% on a pro forma basis, at constant exchange rates.

If the positive impact of the merger with the Pfizer consumer healthcare business is included, sales are up 25% for the division in the period.

Reported group sales for the period were up 11% at constant exchange rates (+6% on a pro forma basis), to £9.4 billion (€10.89 billion).

'Good Progress'

“GSK has made further good progress in Q3, with sales growth across all three businesses, and we have today upgraded our full-year EPS guidance," commented Emma Walmsley, GSK chief executive.

"We also achieved a significant milestone with the completion of our new Consumer Healthcare Joint Venture with Pfizer, to create a new world leading consumer healthcare business.”

GSK anticipates 2019 adjusted EPS to be flat for the full year, at constant exchange rates.

© 2019 European Supermarket Magazine – your source for the latest retail news. Article by Stephen Wynne-Jones. Click subscribe to sign up to ESM: The European Supermarket Magazine.

Stay Connected With Our Weekly Newsletter

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our Terms & Conditions and Privacy Policy
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days